Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 24
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer
Dave Bloom
-
2025/11/21
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children
RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies
ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy
News Wire ~ 3rd Party Press Release
-
2018/10/24
0
DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy
News Wire ~ 3rd Party Press Release
-
2018/10/23
0
Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...
News Wire ~ 3rd Party Press Release
-
2018/10/15
0
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...
Dave Bloom
-
2018/09/27
1
Company Developing Peanut Immunotherapy Toothpaste Meets with FDA
News Wire ~ 3rd Party Press Release
-
2018/09/06
0
FDA Grants Fast Track Designation for Epinephrine Nasal Spray as Investigational...
News Wire ~ 3rd Party Press Release
-
2018/08/30
0
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
News Wire ~ 3rd Party Press Release
-
2018/08/13
0
Epinephrine Nasal Spray for Anaphylaxis Shows Promise as Potential Alternative to...
News Wire ~ 3rd Party Press Release
-
2018/06/18
0
Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...
Dave Bloom
-
2018/05/29
0
Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate
Dave Bloom
-
2018/05/25
0
1
...
23
24
25
...
30
Page 24 of 30